RepliCel Life Sciences

RepliCel Life Sciences engages in developing hair follicle cell replication technology for patients suffering from androgenetic alopecia. Learn more

Launch date

2010

Employees

Market cap

Enterprise valuation

€2m (Public information from Jul 2024)

North Vancouver British Columbia (HQ)

http://replicel.com

https://twitter.com/replicel https://www.facebook.com/replicel https://www.linkedin.com/company/replicel-life-sciences-inc-

Authorizing premium user...